Search
Results 11-20 of 27 (Search time: 0.002 seconds).
Item hits:
| Issue Date | Title | Author(s) |
|---|
| 2015-07 | A Randomized, Multicenter, Double-blind, Placebo-controlled, 3 x 3 Factorial Design, Phase II Study to Evaluate the Efficacy and Safety of the Combination of Fimasartan/Amlodipine in Patients With Essential Hypertension | 신진호 |
| 2014-12 | Efficacy and Safety of 30-Mg Fimasartan for the Treatment of Patients With Mild to Moderate Hypertension: An 8-Week, Multicenter, Randomized, Double-Blind, Phase III Clinical Study | 신진호 |
| 2015-12 | A Randomized, Multicenter, Double-Blind, Placebo-Controlled, 3 × 3 Factorial Design, Phase II Study to Evaluate the Efficacy and Safety of the Combination of Fimasartan/Amlodipine in Patients With Essential Hypertension | 신진호 |
| 2014-04 | Comparison Between an Automated Device and a Manual Mercury Sphygmomanometer in an Epidemiological Survey of Hypertension Prevalence | 신진호 |
| 2019-02 | Efficacy of a fixed dose combination of irbesartan and atorvastatin (Rovelito®) in Korean adults with hypertension and hypercholesterolemia | 신진호 |
| 2019-11 | Diversity of and initiatives for hypertension management in Asia—Why we need the HOPE Asia Network | 신진호 |
| 2020-01 | What is new in the 2018 Chinese hypertension guideline and the implication for the management of hypertension in Asia? | 신진호 |
| 2020-01 | An overview of hypertension and cardiac involvement in Asia: Focus on heart failure | 신진호 |
| 2019-12 | 2020 Consensus summary on the management of hypertension in Asia from the HOPE Asia Network | 신진호 |
| 2019-12 | Highlights of the 2019 Japanese Society of Hypertension Guidelines and perspectives on the management of Asian hypertensive patients | 신진호 |
Discover
